1125 related articles for article (PubMed ID: 18849306)
1. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
2. Management of Graves' disease during pregnancy in the Poitou-Charentes Region.
Hawken C; Sarreau M; Bernardin M; Delcourt AC; Muller A; Lefort G; Pernollet P; Marechaud R
Ann Endocrinol (Paris); 2016 Oct; 77(5):570-577. PubMed ID: 27375108
[TBL] [Abstract][Full Text] [Related]
3. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
4. Important considerations in the management of Graves' disease in pregnant women.
Okosieme OE; Lazarus JH
Expert Rev Clin Immunol; 2015; 11(8):947-57. PubMed ID: 26041458
[TBL] [Abstract][Full Text] [Related]
5. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
6. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
8. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
9. [Basedow's disease].
Scheidegger K
Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring.
Gietka-Czernel M; Dębska M; Kretowicz P; Zgliczyński W; Ołtarzewski M
Endokrynol Pol; 2014; 65(4):259-68. PubMed ID: 25185847
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
Caron P
J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
[TBL] [Abstract][Full Text] [Related]
15. Management of Graves Disease: A Review.
Burch HB; Cooper DS
JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
[TBL] [Abstract][Full Text] [Related]
16. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
18. Increased size and vascularisation, plus decreased echogenicity, of foetal thyroid in two-dimensional ultrasonography caused by maternal Graves' disease.
Gietka-Czernel M; Dębska M; Kretowicz P; Jastrzębska H; Zgliczyński W
Endokrynol Pol; 2014; 65(1):64-8. PubMed ID: 24549604
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.
Atkins P; Cohen SB; Phillips BJ
Drug Saf; 2000 Sep; 23(3):229-44. PubMed ID: 11005705
[TBL] [Abstract][Full Text] [Related]
20. Severe fetal and neonatal hyperthyroidism years after surgical treatment of maternal Graves' disease.
Dierickx I; Decallonne B; Billen J; Vanhole C; Lewi L; De Catte L; Verhaeghe J
J Obstet Gynaecol; 2014 Feb; 34(2):117-22. PubMed ID: 24456429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
